Peer review is the system used to assess the quality of a manuscript before it is published. Independent researchers in the relevant research area assess submitted manuscripts for originality, validity and significance to help Editors determine whether the manuscript should be published in their journal. You can read more about the peer-review process here.
Genome Medicine operates a single-blind peer-review system, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous. The benefit of single-blind peer review is that it is the traditional model of peer review that many reviewers are comfortable with, and it facilitates a dispassionate critique of a manuscript.
Manuscripts submitted to Genome Medicine are assessed by our experienced in-house editorial team, who make all decisions based on extensive and rigorous peer review by academic experts who specialize in the manuscript topic. Editorial Board Members may provide advice on manuscripts submitted to the journal but are not involved in the final decisions. The overall editorial responsibility for the journal is with the Chief Editor.
We aim to provide our readership with the highest quality research and information in genomic and post-genomic medicine, and will therefore focus on articles of general and outstanding interest. We welcome presubmission enquiries by email.